Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 18;32(2):101247.
doi: 10.1016/j.omtm.2024.101247. eCollection 2024 Jun 13.

It's all about location: Targeting the right spot for Wiskott-Aldrich syndrome

Affiliations

It's all about location: Targeting the right spot for Wiskott-Aldrich syndrome

Asma Naseem et al. Mol Ther Methods Clin Dev. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Schematic illustration of the gene editing approach used in this study in various cell types and the outcomes

References

    1. Vieira R.C., Pinho L.G., Westerberg L.S. Understanding immunoactinopathies: A decade of research on WAS gene defects. Pediatr. Allergy Immunol. 2023;34 doi: 10.1111/pai.13951. - DOI - PubMed
    1. Pille M., Avila J.M., Park S.H., Le C.Q., Xue H., Haerynck F., Saxena L., Lee C., Shpall E.J., Bao G., et al. Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome. Mol. Ther. Methods Clin. Dev. 2024;32 doi: 10.1016/j.omtm.2024.101208. - DOI - PMC - PubMed
    1. Rai R., Romito M., Rivers E., Turchiano G., Blattner G., Vetharoy W., Ladon D., Andrieux G., Zhang F., Zinicola M., et al. Targeted gene correction of human hematopoietic stem cells for the treatment of wiskott - Aldrich syndrome. Nat. Commun. 2020;11:4034. - PMC - PubMed
    1. Aiuti A., Biasco L., Scaramuzza S., Ferrua F., Cicalese M.P., Baricordi C., Dionisio F., Calabria A., Giannelli S., Castiello M.C., et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science. 2013;341 doi: 10.1126/science.1233151. - DOI - PMC - PubMed
    1. Hacein-Bey Abina S., Gaspar H.B., Blondeau J., Caccavelli L., Charrier S., Buckland K., Picard C., Six E., Himoudi N., Gilmour K., et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA. 2015;313:1550–1563. doi: 10.1001/jama.2015.3253. - DOI - PMC - PubMed

LinkOut - more resources